NM_001613.4:c.455-17G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001613.4(ACTA2):​c.455-17G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00842 in 1,613,720 control chromosomes in the GnomAD database, including 397 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 43 hom., cov: 32)
Exomes 𝑓: 0.0084 ( 354 hom. )

Consequence

ACTA2
NM_001613.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.325

Publications

4 publications found
Variant links:
Genes affected
ACTA2 (HGNC:130): (actin alpha 2, smooth muscle) This gene encodes one of six different actin proteins. Actins are highly conserved proteins that are involved in cell motility, structure, integrity, and intercellular signaling. The encoded protein is a smooth muscle actin that is involved in vascular contractility and blood pressure homeostasis. Mutations in this gene cause a variety of vascular diseases, such as thoracic aortic disease, coronary artery disease, stroke, and Moyamoya disease, as well as multisystemic smooth muscle dysfunction syndrome. [provided by RefSeq, Sep 2017]
STAMBPL1 (HGNC:24105): (STAM binding protein like 1) Predicted to enable Lys63-specific deubiquitinase activity and thiol-dependent deubiquitinase. Predicted to be involved in protein K63-linked deubiquitination. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 10-88941407-C-T is Benign according to our data. Variant chr10-88941407-C-T is described in ClinVar as Benign. ClinVar VariationId is 35644.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.114 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001613.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTA2
NM_001613.4
MANE Select
c.455-17G>A
intron
N/ANP_001604.1
ACTA2
NM_001141945.3
c.455-17G>A
intron
N/ANP_001135417.1
ACTA2
NM_001320855.2
c.455-17G>A
intron
N/ANP_001307784.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTA2
ENST00000224784.10
TSL:1 MANE Select
c.455-17G>A
intron
N/AENSP00000224784.6
STAMBPL1
ENST00000371927.7
TSL:2
c.1254+18971C>T
intron
N/AENSP00000360995.3
ACTA2
ENST00000713598.1
c.497-17G>A
intron
N/AENSP00000518894.1

Frequencies

GnomAD3 genomes
AF:
0.00836
AC:
1271
AN:
151998
Hom.:
43
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00191
Gnomad AMI
AF:
0.00440
Gnomad AMR
AF:
0.00419
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.121
Gnomad SAS
AF:
0.0214
Gnomad FIN
AF:
0.000568
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00503
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.0146
AC:
3656
AN:
250896
AF XY:
0.0145
show subpopulations
Gnomad AFR exome
AF:
0.00221
Gnomad AMR exome
AF:
0.00283
Gnomad ASJ exome
AF:
0.00408
Gnomad EAS exome
AF:
0.132
Gnomad FIN exome
AF:
0.000416
Gnomad NFE exome
AF:
0.00500
Gnomad OTH exome
AF:
0.00914
GnomAD4 exome
AF:
0.00842
AC:
12305
AN:
1461606
Hom.:
354
Cov.:
31
AF XY:
0.00873
AC XY:
6348
AN XY:
727110
show subpopulations
African (AFR)
AF:
0.00134
AC:
45
AN:
33470
American (AMR)
AF:
0.00271
AC:
121
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00390
AC:
102
AN:
26128
East Asian (EAS)
AF:
0.118
AC:
4676
AN:
39636
South Asian (SAS)
AF:
0.0151
AC:
1302
AN:
86254
European-Finnish (FIN)
AF:
0.000543
AC:
29
AN:
53410
Middle Eastern (MID)
AF:
0.00919
AC:
53
AN:
5766
European-Non Finnish (NFE)
AF:
0.00473
AC:
5258
AN:
1111844
Other (OTH)
AF:
0.0119
AC:
719
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
647
1293
1940
2586
3233
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00839
AC:
1276
AN:
152114
Hom.:
43
Cov.:
32
AF XY:
0.00923
AC XY:
686
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.00190
AC:
79
AN:
41490
American (AMR)
AF:
0.00419
AC:
64
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00605
AC:
21
AN:
3472
East Asian (EAS)
AF:
0.121
AC:
627
AN:
5164
South Asian (SAS)
AF:
0.0216
AC:
104
AN:
4810
European-Finnish (FIN)
AF:
0.000568
AC:
6
AN:
10570
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00503
AC:
342
AN:
68008
Other (OTH)
AF:
0.0123
AC:
26
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
66
132
198
264
330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00851
Hom.:
23
Bravo
AF:
0.00941
Asia WGS
AF:
0.0750
AC:
260
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Mar 21, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Familial aortopathy Benign:1
Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Aortic aneurysm, familial thoracic 6 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.4
DANN
Benign
0.60
PhyloP100
-0.33
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3816245; hg19: chr10-90701164; COSMIC: COSV56516719; COSMIC: COSV56516719; API